Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
darunavir (prezista) (2 trials)
dolutegravir (tivicay) (4 trials)
ritonavir (Norvir) (4 trials)
abacavir (ziagen) (2 trials)
albendazole (Albenza) (1 trial)
efavirenz (sustiva) (1 trial)
ivermectin (stromectol) (1 trial)
lamivudine (epivir) (2 trials)
lopinavir (Kaletra) (2 trials)
zidovudine (retrovir) (1 trial)
rituximab (rituxan) (1 trial)
Coinfection (Phase 4)
Communicable Diseases (Phase 4)
Cytomegalovirus Infections (Phase 4)
Epstein-Barr Virus Infections (Phase 4)
Infections (Phase 4)
Inflammation (Phase 4)
Papilloma (Phase 4)
Trials (7 total)
Trial APIs (11 total)
